CYTK - CYTOKINETICS INC

QQQ $ 454.82 $ 0.26 (0.06 %)

DIA $ 398.57 $ -2.12 (-0.53 %)

SPY $ 530.36 $ -1.53 (-0.29 %)

TLT $ 91.26 $ 0.11 (0.12 %)

GLD $ 225.37 $ -0.52 (-0.24 %)

Previous Close

$ 59.23

Open

$ 60.20

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 58.81 - $ 60.95

52 Week Range

$ 25.98 - $ 110.25

Volume

1,499,174

Average Volume

Market Cap

6.04B

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-10-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-03-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-05-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-04-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-06-2022	03-31-2022	10-Q
10	02-25-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-06-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	02-26-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	03-04-2020	12-31-2019	10-K
19	11-01-2019	09-30-2019	10-Q
20	08-09-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-07-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-05-2018	12-31-2017	10-K
27	11-03-2017	09-30-2017	10-Q
28	08-04-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	03-06-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	03-03-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-05-2015	06-30-2015	10-Q
37	05-04-2015	03-31-2015	10-Q
38	03-06-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Market-Moving News for May 23rd
05/23/2024 12:40:36

NVDA: 7.77% | NVIDIA shares are trading higher after the company reported better-than-expected Q1 2025 financial results and is...

why-nvidia-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Why NVIDIA Shares Are Trading Higher By Ov...
05/23/2024 12:39:23

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
05/23/2024 12:06:48

nvidia-to-rally-over-39-here-are-10-top-analyst-forecasts-for-thursday

NVIDIA To Rally Over 39%? Here Are 10 Top ...
05/23/2024 11:48:17

Needham Maintains Buy on Cytokinetics, Low...
05/23/2024 10:55:24

Needham analyst Serge Belanger maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target from $108 to $72.

vf-corp-posts-weak-q4-results-joins-netease-cytokinetics-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

VF Corp Posts Weak Q4 Results, Joins NetEa...
05/23/2024 09:39:33

Reported Earlier, Cytokinetics Prices Publ...
05/23/2024 06:17:11

The gross proceeds to Cytokinetics from the offering, before deducting underwriting discounts and commissions and other offerin...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
05/22/2024 20:31:33

Cytokinetics Plans Proposed Public Offerin...
05/22/2024 20:02:59

Cytokinetics expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of c...

Cytokinetics And Royalty Pharma Enter Fund...
05/22/2024 20:02:52

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
05/17/2024 17:35:23

'Amid Acquisition Speculation, Cytokinetic...
05/17/2024 14:50:41

https://www.statnews.com/2024/05/17/cytokinetics-robert-blum-stat-breakthrough-summit-west/ As Cytokinetics faces pressure to s...

JMP Securities Reiterates Market Outperfor...
05/14/2024 17:25:56

JMP Securities analyst Jason Butler reiterates Cytokinetics (NASDAQ:CYTK) with a Market Outperform and maintains $106 price ...

HC Wainwright & Co. Reiterates Buy on Cyto...
05/14/2024 11:16:54

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $94 price ta...

Needham Reiterates Buy on Cytokinetics, Ma...
05/14/2024 09:34:43

Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $108 price target.

Cytokinetics Presents Additional Results F...
05/13/2024 13:34:41

Analyses of SEQUOIA-HCM Elaborate on Dosing and Measures of Safety During Treatment with AficamtenResults from Cardiopulmonary ...

HC Wainwright & Co. Reiterates Buy on Cyto...
05/09/2024 19:33:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $94 price ta...

JMP Securities Maintains Market Outperform...
05/09/2024 18:26:15

JMP Securities analyst Jason Butler maintains Cytokinetics (NASDAQ:CYTK) with a Market Outperform and lowers the price targe...

Oppenheimer Maintains Outperform on Cytoki...
05/09/2024 16:47:53

Oppenheimer analyst Justin Kim maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and lowers the price target from $107 ...

Needham Reiterates Buy on Cytokinetics, Ma...
05/09/2024 13:43:40

Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $108 price target.